Results 121 to 130 of about 332,491 (297)
Discovery and restoration of Aberrant Nuclear structure and Genome behaviour in breast cancer cells [PDF]
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel University.The eukaryotic interphase nucleus is well organised and the genome positioned non-randomly.
Hassan Ahmed, Mai
core
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
From 1993 to 2013, tacrine was an approved drug for Alzheimer’s disease. Due to its strong inhibitory properties towards cholinesterase, tacrine causes an increase in the level of the neurotransmitter acetylcholine in the cholinergic system of the ...
Przemysław Koźmiński, Ewa Gniazdowska
doaj +1 more source
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
Lapatinib-Based Radioagents for Application in Nuclear Medicine
Lapatinib is an approved therapeutic agent for the treatment of HER2-positive breast cancer. It has a high affinity for the non-receptor cytoplasmic tyrosine kinases of the EGFR and HER2 receptors. It is a type II inhibitor, with Kiapp values of 3 nM and
Przemysław Koźmiński, Ewa Gniazdowska
doaj +1 more source
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Atomic Energy Commission Report AECU-2494
This is the 28th progress report of the Laboratory for Nuclear Science at the Massachusetts Institute of Technology. Progress during the period November 30, 1952 to February 28, 1953 is reported under the following headings: Chemistry of the Fission ...
Massachusetts Institute of Technology. Laboratory for Nuclear Science.
core
Finding novel vulnerabilities of hypomorphic BRCA1 alleles
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder +10 more
wiley +1 more source
Emphasizing new science essential to the practice of environmental chemistry at the beginning of the new millennium, this book describes the atmosphere as a distinct sphere of the environment and the practice of industrial ecology as it applies to ...
Clark, Herbert M. +4 more
core
The synthesis and chemistry of model compounds related to fluoropolybcers [PDF]
The objectives of this research project were to synthesize and investigate the chemistry of model compounds related to the hexafluoropropene/vinylidene fluoride copolymer system.
Apsey, Glenn C.
core

